Gastric and Esophageal

Esophagus, Lung, Melanoma, SkinA Phase 1 Study to Investigate PF-08046033 in Participants With Advanced Solid Tumors
Esophagus, StomachAACR Adaptive Biomarker-Driven Organ Preservation Trial In Gastroesophageal Adenocarcinomas (AACR-ADOPT-GEA)
Esophagus, Pancreas, StomachA Phase 1a/b, Multicenter, Open-label, First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Anus, Breast, Colon, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Other Digestive Organ, Pancreas, Phase I, Rectum, Small Intestine, Stomach, ThyroidAn Open-label, Phase 1a/b, Multicenter Study of ZL-6201 to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy in Participants With Sarcoma and Selected Solid Tumors
Breast, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Other Urinary, Phase I, ThyroidFirst-In-Human, Open-Label, Dose Escalation and Expansion Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of GEN1106 in Participants With Solid Tumors